# HEPCLUDEX

NDC: 61958-3104
Generic name: BULEVIRTIDE
Labeler / Manufacturer: Gilead Sciences, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20260522

FDA application: BLA761468

## Active ingredients

- BULEVIRTIDE ACETATE: 8.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61958-3104"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61958-3104
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12391cc2-38c2-4cf5-86d3-2be9370127fc